| [1] |
Zhang H, Kobayashi R, Galaktionov K, et al. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell, 1995, 82(6): 915-925.
|
| [2] |
Demetrick DJ, Zhang H, Beach DH. Chromosomal mapping of the genes for the human CDK2/cyclin A-associated proteins p19 (SKP1A and SKP1B) and p45(SKP2). Cytogenet Cell Genet, 1996, 73(1-2): 104-107.
|
| [3] |
Wang Z, Gao D, Fukushima H, et al. Skp2: A novel potential therapeutic target for prostate cancer. Biochim Biophys Acta, 2012, 1825(1): 11-17.
|
| [4] |
Lin DC, Du XL, Wang MR. Protein alterations in ESCC and clinical implications: a review. Dis Esophagus, 2009, 22(1): 9-20.
|
| [5] |
Gstaiger M, Jordan R, Lim M, et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA, 2001, 98(9): 5043-5048.
|
| [6] |
Yokoi S, Yasui K, Saito-Ohara F, et al. A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol, 2002, 161(1): 207-216.
|
| [7] |
Arbini AA, Greco M, Yao JL, et al. Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer. Am J Pathol, 2011, 178(5): 2367-2376.
|
| [8] |
Wang Z, Fukushima H, Inuzuka H, et al. Skp2 is a promising therapeutic target in breast cancer. Front Oncol, 2012, 1(57): pii18702.
|
| [9] |
Ma XM, Liu Y, Guo JW, et al. Relation of overexpression of S phase kinase-associated protein 2 with reduced expression of p27 and PTEN in human gastric carcinoma. World J Gastroenterol, 2005, 11(42): 6716-6721.
|
| [10] |
Fujita T, Liu W, Doihara H, et al. Regulation of Skp2-p27 axis by the Cdh1/anaphase-promoting complex pathway in colorectal tumorigenesis. Am J Pathol, 2008, 173(1): 217-228.
|